Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Feb;42(1):63–66. doi: 10.1136/ard.42.1.63

HLA DR antigens and gold toxicity.

J T Gran, G Husby, E Thorsby
PMCID: PMC1001062  PMID: 6402993

Abstract

One hundred and thirty-two patients with rheumatoid arthritis treated with gold have been studied for possible associations between HLA DR antigens and different adverse reactions occurring during such therapy. Patients possessing HLA DR3 had a significantly greater frequency of side effects than patients lacking this antigen. It was particularly noticed that DR3 positive patients on gold treatment had an 11 times higher risk of getting proteinuria than those without DR3. The lowest frequency of side effects was seen in DR7 positives. No significant differences between the DR antigen groups with respect to skin eruptions, liver reactions, or leucopenia were evident.

Full text

PDF
63

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. KIRPILA J., RIPATTI N. Nivelreuman kultahoidon komplikaatioista. Duodecim. 1957;73(10):597–608. [PubMed] [Google Scholar]
  2. Karr R. W., Rodey G. E., Lee T., Schwartz B. D. Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum. 1980 Nov;23(11):1241–1245. doi: 10.1002/art.1780231102. [DOI] [PubMed] [Google Scholar]
  3. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  5. Scherak O., Smolen J. S., Mayr W. R. HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum. 1980 Aug;23(8):954–957. doi: 10.1002/art.1780230815. [DOI] [PubMed] [Google Scholar]
  6. Thorsby E. The human major histocompatibility complex HLA: some recent developments. Transplant Proc. 1979 Mar;11(1):616–623. [PubMed] [Google Scholar]
  7. Tönroth T., Skrifvars B. Gold nephropathy prototype of membranous glomerulonephritis. Am J Pathol. 1974 Jun;75(3):573–590. [PMC free article] [PubMed] [Google Scholar]
  8. Wooley P. H., Griffin J., Panayi G. S., Batchelor J. R., Welsh K. I., Gibson T. J. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med. 1980 Aug 7;303(6):300–302. doi: 10.1056/NEJM198008073030602. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES